In a significant advancement for women's health, the U.S. Food and Drug Administration (FDA) has approved the Teal Wand™, the first and only at-home self-collection device for cervical cancer screening in the United States. Developed by Teal Health, this innovative tool allows women to collect their own vaginal samples from the comfort of their homes, eliminating the need for traditional in-clinic Pap smears.
The Teal Wand™ is designed for women aged 25 to 65 at average risk for cervical cancer. After obtaining a prescription through Teal Health's telehealth services, users receive a kit to collect a sample, which is then mailed to a certified laboratory for analysis. The testing process utilizes the same highly accurate HPV test used in clinical settings, ensuring reliable results.
